Literature DB >> 2012175

Immunobiochemical and molecular biologic characterization of the cell proliferation-associated nuclear antigen that is defined by monoclonal antibody Ki-67.

J Gerdes1, L Li, C Schlueter, M Duchrow, C Wohlenberg, C Gerlach, I Stahmer, S Kloth, E Brandt, H D Flad.   

Abstract

The monoclonal antibody Ki-67 detects a human nuclear antigen that is present in proliferating cells, but absent in quiescent cells. The aim of this study was to characterize the Ki-67 antigen by means of immunobiochemical and molecular biology techniques. Enzymatic digestion experiments showed that this antigen is highly susceptible to protease treatment, and the antigen cannot be extracted by 0.1 normal HCl, indicating that Ki-67 antigen is a nonhistone protein. Immunoblot analysis of cell lysates with Ki-67 showed a double band with apparent molecular weights of 395 kd and 345 kd, regardless of whether the gels were run under reducing or nonreducing conditions. It is noteworthy that these bands were exclusively detectable in lysates prepared from proliferating cells, whereas they were absent in lysates obtained from quiescent cells. These immunobiochemical data are further substantiated by our molecular cloning approaches. By means of immunocloning with Ki-67, the authors isolated and sequenced several cDNA fragments from lambda gt11 libraries. A 1095-bp fragment gave a strong hybridization signal at 7.5 to 9.5 kb in Northern blot analysis with RNA prepared from proliferating cells, whereas it was negative with RNA prepared from quiescent cells. This cDNA fragment could be bacterially expressed, and in subsequent immunoblot analysis Ki-67 reacted exclusively with those fusion proteins that were derived from bacteria containing the insert in the right reading frame.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2012175      PMCID: PMC1886092     

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  38 in total

Review 1.  Fusion proteins in retroviral transformation.

Authors:  K Moelling
Journal:  Adv Cancer Res       Date:  1985       Impact factor: 6.242

Review 2.  DNA topoisomerases.

Authors:  J C Wang
Journal:  Annu Rev Biochem       Date:  1985       Impact factor: 23.643

3.  Use of freeze-dried paraffin-embedded sections for immunohistologic staining with monoclonal antibodies.

Authors:  H Stein; K Gatter; H Asbahr; D Y Mason
Journal:  Lab Invest       Date:  1985-06       Impact factor: 5.662

4.  Cell cycle analysis of a cell proliferation-associated human nuclear antigen defined by the monoclonal antibody Ki-67.

Authors:  J Gerdes; H Lemke; H Baisch; H H Wacker; U Schwab; H Stein
Journal:  J Immunol       Date:  1984-10       Impact factor: 5.422

5.  Growth fractions in malignant non-Hodgkin's lymphomas (NHL) as determined in situ with the monoclonal antibody Ki-67.

Authors:  J Gerdes; F Dallenbach; K Lennert; H Lemke; H Stein
Journal:  Hematol Oncol       Date:  1984 Oct-Dec       Impact factor: 5.271

6.  New approach to assessing lung tumours in man.

Authors:  K C Gatter; M S Dunnill; J Gerdes; H Stein; D Y Mason
Journal:  J Clin Pathol       Date:  1986-06       Impact factor: 3.411

7.  Expression of a cell-cycle-associated nuclear antigen (Ki-67) in cutaneous lymphoid infiltrates.

Authors:  E Ralfkiaer; H Stein; J Bosq; K C Gatter; N Ralfkiaer; G L Wantzin; D Y Mason
Journal:  Am J Dermatopathol       Date:  1986-02       Impact factor: 1.533

8.  Rapid and sensitive colorimetric method for visualizing biotin-labeled DNA probes hybridized to DNA or RNA immobilized on nitrocellulose: Bio-blots.

Authors:  J J Leary; D J Brigati; D C Ward
Journal:  Proc Natl Acad Sci U S A       Date:  1983-07       Impact factor: 11.205

9.  Versatile expression vectors for high-level synthesis of cloned gene products in Escherichia coli.

Authors:  R Crowl; C Seamans; P Lomedico; S McAndrew
Journal:  Gene       Date:  1985       Impact factor: 3.688

10.  Ki-67 detects a nuclear matrix-associated proliferation-related antigen. II. Localization in mitotic cells and association with chromosomes.

Authors:  R Verheijen; H J Kuijpers; R van Driel; J L Beck; J H van Dierendonck; G J Brakenhoff; F C Ramaekers
Journal:  J Cell Sci       Date:  1989-04       Impact factor: 5.285

View more
  201 in total

1.  Ki-67: a useful marker for the evaluation of dysplasia in ulcerative colitis.

Authors:  S N Andersen; T O Rognum; A Bakka; O P Clausen
Journal:  Mol Pathol       Date:  1998-12

2.  Three-dimensional organization of pKi-67: a comparative fluorescence and electron tomography study using FluoroNanogold.

Authors:  Thierry Cheutin; Marie-Françoise O'Donohue; Adrien Beorchia; Christophe Klein; Hervé Kaplan; Dominique Ploton
Journal:  J Histochem Cytochem       Date:  2003-11       Impact factor: 2.479

Review 3.  Clinicopathological and prognostic significance of high Ki-67 labeling index in hepatocellular carcinoma patients: a meta-analysis.

Authors:  Yihuan Luo; Fanghui Ren; Yongru Liu; Zhenhong Shi; Zhong Tan; Huojie Xiong; Yiwu Dang; Gang Chen
Journal:  Int J Clin Exp Med       Date:  2015-07-15

4.  Proteomic analysis of the Kaposi's sarcoma-associated herpesvirus terminal repeat element binding proteins.

Authors:  Huaxin Si; Subhash C Verma; Erle S Robertson
Journal:  J Virol       Date:  2006-09       Impact factor: 5.103

5.  Ki67: from antibody to molecule to understanding?

Authors:  W Ross; P A Hall
Journal:  Clin Mol Pathol       Date:  1995-06

6.  Prognostic value of loss of heterozygosity around three candidate tumor suppressor genes on chromosome 10q in astrocytomas.

Authors:  Kinya Terada; Takashi Tamiya; Shigeru Daido; Hirokazu Kambara; Hiroaki Tanaka; Yasuhiro Ono; Kengo Matsumoto; Sachio Ito; Mamoru Ouchida; Takashi Ohmoto; Kenji Shimizu
Journal:  J Neurooncol       Date:  2002-06       Impact factor: 4.130

7.  Transformation to small-cell lung cancer following treatment with icotinib in a patient with lung adenocarcinoma.

Authors:  Hongyang Lu; Bo Chen; Jing Qin; Fajun Xie; Na Han; Zhiyu Huang
Journal:  Oncol Lett       Date:  2018-02-13       Impact factor: 2.967

8.  Determination of the growth fraction in non-Hodgkin's lymphomas by monoclonal antibody Ki-S5 directed against a formalin-resistant epitope of the Ki-67 antigen.

Authors:  H Kreipe; H H Wacker; H J Heidebrecht; K Haas; M Hauberg; M Tiemann; R Parwaresch
Journal:  Am J Pathol       Date:  1993-06       Impact factor: 4.307

9.  Correlations between apoptotic and proliferative indices in malignant non-Hodgkin's lymphomas.

Authors:  L Leoncini; M T Del Vecchio; T Megha; P Barbini; P Galieni; S Pileri; E Sabattini; F Gherlinzoni; P Tosi; R Kraft
Journal:  Am J Pathol       Date:  1993-03       Impact factor: 4.307

10.  PCNA and Ki-67 in central nervous system tumors: correlation with the histological type and grade.

Authors:  Fazilet Kayaselçuk; Suzan Zorludemir; Derya Gümürdühü; Handan Zeren; Tahsin Erman
Journal:  J Neurooncol       Date:  2002-04       Impact factor: 4.130

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.